Navigation Links
Gene-silencing data now publicly available to help scientists better understand disease
Date:12/11/2013

bi.nlm.nih.gov.

"Translation of siRNA library screening results into impactful downstream experiments is the ultimate goal of scientists using our library," said Alan Sachs, M.D., Ph.D., head of global research and development for Life Technologies. "The availability of these sequence data should greatly facilitate this effort because scientists no longer will be blinded to the actual sequence they are targeting."


'/>"/>

Contact: NCATS Communications
info@ncats.nih.gov
301-435-0888
NIH/National Center for Advancing Translational Sciences (NCATS)
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Gene-silencing study finds new targets for Parkinsons disease
2. James Cameron to be publicly honored with Scripps Nierenberg Prize
3. 2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
4. Research4Life greatly expands peer-reviewed research available to developing world
5. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
6. uAttend Time Tracking Solutions Available at TimeClockDeals.com
7. New Market Forecasts Available for Critical Global Biotechnology Testing and Screening Markets: Molecular Diagnostics, Hematology, Clinical Chemistry and Nucleic Acid Testing
8. New edition of Bacterial Genetics text available
9. University-developed omega-3-rich ground beef available soon
10. Over 12,000 Wiley Online Books made available in developing countries via Research4Life
11. EAU Patient Information now available in Spanish and Greek
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/rswjb4/hand_geometry ) ... Global Strategic Business Report" report to their offering. ... in US$ Thousands. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific ... of World. Annual estimates and forecasts are provided ...
(Date:3/19/2015)... March 19, 2015  NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, announces its biometric payment ... clip that aired this week on Washington DC,s ... In a segment "The Next Great Thing", host ... way to pay, and ,a really big breakthrough in mobile ...
(Date:3/17/2015)... Emotient, the leader in facial expression ... availability of Emotient Analytics , the world,s ... facial expressions. The system analyzes videos of people ... services. It delivers audience response metrics - such ... derived from facial evidence of emotional states. Consumer ...
Breaking Biology News(10 mins):Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 2Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 3Hand Geometry - Global Strategic Business Report 2015: An Essential Security Component for both Government & Enterprise Sector 4NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... lawn grass come equipped with their own natural broad-spectrum ... plants around them., Cornell researchers have identified the ... that these lawn grasses exude from their roots in ... of para-tyrosine (p-tyrosine), one of the 20 common amino ...
... 7, 2007) FIJI Water, one of the fastest ... announced a Sustainable Growth Initiative today that will make ... achieve this, FIJI Water will account for the carbon ... then, through a combination of meaningful reductions and carbon-reducing ...
... Mass., Nov. 7, 2007 -- Researchers at Harvard University ... by nature, to reduce the accumulation of atmospheric carbon ... By electrochemically removing hydrochloric acid from the ocean ... (volcanic) rocks, the researchers say they can accelerate natural ...
Cached Biology News:Researchers discover natural herbicide released by grass 2FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 2FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 3FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 4FIJI Water announces sustainable growth initiative with commitment to help mitigate climate change 5Engineered weathering process could mitigate global warming 2Engineered weathering process could mitigate global warming 3
(Date:4/17/2015)... 2015 LC Sciences LLC, a ... today that it is seeking beta testers for ... PCR based targeted sequencing technology. The system offers ... enables accurate detection of rare variants. It utilizes ... The company will collaborate with beta testers to ...
(Date:4/16/2015)... CA (PRWEB) April 16, 2015 Cytokinetics, ... to report first quarter results on Thursday, April 30, ... Cytokinetics’ senior management will host a conference call at ... results and the company’s outlook for the future. , ... be accessed from the homepage and in the Investor ...
(Date:4/16/2015)... April 16, 2015 According to ... involving an outside source was ranked first among ... injuries related to lifting, pushing, pulling, holding, carrying, ... direct costs. The David Round Company takes statistics ... to working hard to develop and design equipment ...
(Date:4/16/2015)... April 16, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... U.S. joint venture with G-treeBNT (ReGenTree LLC) has ... clinical trial for the orphan disorder, neurotrophic keratopathy ... dry eye syndrome (DES) in the U.S.  Both ... RGN-259/GBT201, this year.  Each of these eye disorders ...
Breaking Biology Technology:LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3Cytokinetics to Announce First Quarter Results on April 30, 2015 2Cytokinetics to Announce First Quarter Results on April 30, 2015 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 2RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 3RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 4RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S. 5
... 17 Genzyme Corp.,(Nasdaq: GENZ ) announced ... has approved a supplemental indication for Thyrogen(R) (thyrotropin,alfa ... radioiodine to ablate,or destroy, the remaining thyroid tissue ... Remnant ablation is a procedure that patients,commonly undergo ...
... Patients Had Confirmed Partial Responses (25%); ... Breast Cancer Symposium, HAYWARD, Calif., Dec. 17 ... announced that its Hsp90 inhibitor,tanespimycin, demonstrated meaningful antitumor ... patients with HER2-positive metastatic breast cancer,when administered in ...
... Va., Dec. 17 Innocoll, Inc., a,privately ... has,closed an equity financing investment to raise ... stock in a private placement with three,institutional ... with NewSmith,Asset Management LLP and Morgan Stanley ...
Cached Biology Technology:Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 2Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 3Genzyme Announces FDA Approval of Thyrogen(R) for Use in Thyroid Cancer Ablation 4Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 2Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 3Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 4Kosan's Hsp90 Inhibitor, Tanespimycin, Shows 55% Clinical Benefit in Patients With Trastuzumab-Refractory Metastatic Breast Cancer 5Innocoll Announces Closing of $30 Million Equity Financing Investment 2Innocoll Announces Closing of $30 Million Equity Financing Investment 3Innocoll Announces Closing of $30 Million Equity Financing Investment 4Innocoll Announces Closing of $30 Million Equity Financing Investment 5
...
Performance, mycoplasma, virus, and endotoxin tested. Collected from calves 14 days old or less...
...
Mus musculus junctophilin 2 (Jph2) Antigen: Recombinant Protein...
Biology Products: